H.Res. 1125 · 116th Congress
Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.
- Stage
- In committee
- Sponsor
- Eliot Engel
- Introduced
- 2020-09-18
- Latest action
- 2020-09-18 · Introduced in House
Subjects
Health care coverage and access
Health
Infectious and parasitic diseases
Medical research
Health programs administration and funding
Medical tests and diagnostic methods
Minority health
Research administration and funding
Emergency medical services and trauma care
Cardiovascular and respiratory health
Immunology and vaccination
Community life and organization